Hena Holdings (a company wholly owned by Dr Hend El Sherbini and Dr Moamena Abdul Wahab Kamel) has made an unrecommended mandatory final cash offer for Egypt-based Integrated Diagnostics Holdings (IDH). The acquisition values the entire issued and to be issued ordinary share capital of IDH at approximately US$290.7m....
Alfasigma, an Italy based, privately owned, medium-sized pharmaceutical company, has entered into a share purchase agreement with Sever Life Sciences for the sale of 100% of the shares of Nordic Group BV and its subsidiaries, a specialty pharmaceutical company with direct operations in Europe, Canada and Japan.
Financial terms are not disclosed.
The acquisition will add Nordic Pharma’s established rheumatoid arthritis business, led by the Nordimet methotrexate franchise, to Alfasigma’s rheumatology portfolio, which includes the Jyseleca franchise. It will also deepen Alfasigma’s commercial reach through direct operations in 18 countries across...